232 related articles for article (PubMed ID: 21227289)
1. Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer.
Knapp DW; Glickman NW; Denicola DB; Bonney PL; Lin TL; Glickman LT
Urol Oncol; 2000; 5(2):47-59. PubMed ID: 21227289
[TBL] [Abstract][Full Text] [Related]
2. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.
Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE
ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.
Hamlin AN; Chadwick LE; Fox-Alvarez SA; Hostnik ET
Vet Radiol Ultrasound; 2019 Sep; 60(5):552-559. PubMed ID: 31144408
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
[TBL] [Abstract][Full Text] [Related]
5. Management of transitional cell carcinoma of the urinary bladder in dogs: a review.
Fulkerson CM; Knapp DW
Vet J; 2015 Aug; 205(2):217-25. PubMed ID: 25747698
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder.
Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T
Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867
[TBL] [Abstract][Full Text] [Related]
7. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.
Knapp DW; Dhawan D; Ramos-Vara JA; Ratliff TL; Cresswell GM; Utturkar S; Sommer BC; Fulkerson CM; Hahn NM
Front Oncol; 2019; 9():1493. PubMed ID: 32039002
[TBL] [Abstract][Full Text] [Related]
8. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.
Arnold EJ; Childress MO; Fourez LM; Tan KM; Stewart JC; Bonney PL; Knapp DW
J Vet Intern Med; 2011; 25(6):1385-90. PubMed ID: 22092632
[TBL] [Abstract][Full Text] [Related]
10. Canine transitional cell carcinoma.
Mutsaers AJ; Widmer WR; Knapp DW
J Vet Intern Med; 2003; 17(2):136-44. PubMed ID: 12683611
[TBL] [Abstract][Full Text] [Related]
11. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
12. Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.
Dhawan D; Paoloni M; Shukradas S; Choudhury DR; Craig BA; Ramos-Vara JA; Hahn N; Bonney PL; Khanna C; Knapp DW
PLoS One; 2015; 10(9):e0136688. PubMed ID: 26352142
[TBL] [Abstract][Full Text] [Related]
13. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Hahn NM; Waddell J; Olbricht GR; Zheng R; Stewart JC; Knapp DW
Urol Oncol; 2013 Nov; 31(8):1761-9. PubMed ID: 22609058
[TBL] [Abstract][Full Text] [Related]
14. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
Vinall RL; Kent MS; deVere White RW
Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T
Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
[TBL] [Abstract][Full Text] [Related]
17. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells.
Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S
Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167
[TBL] [Abstract][Full Text] [Related]
18. NMR-based metabolomics study of canine bladder cancer.
Zhang J; Wei S; Liu L; Nagana Gowda GA; Bonney P; Stewart J; Knapp DW; Raftery D
Biochim Biophys Acta; 2012 Nov; 1822(11):1807-14. PubMed ID: 22967815
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq.
Maeda S; Tomiyasu H; Tsuboi M; Inoue A; Ishihara G; Uchikai T; Chambers JK; Uchida K; Yonezawa T; Matsuki N
BMC Cancer; 2018 Apr; 18(1):472. PubMed ID: 29699519
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.
Mutsaers AJ; Mohammed SI; DeNicola DB; Snyder PW; Glickman NW; Bennett PF; de Gortari AE; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):181-6. PubMed ID: 15664302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]